No Data
Is Dalian BIO-CHEM Company Limited's (SHSE:603360) Latest Stock Performance A Reflection Of Its Financial Health?
Dalian BIO-CHEM PLans 10-Million-Yuan Investment in Semiconductor Industry
Dalian bio-chem (603360.SH): Plans to establish a wholly-owned subsidiary with 10 million yuan for further investment in the semiconductor industry.
On November 25, Gelonghui reported that dalian bio-chem (603360.SH) announced its plan to establish a wholly-owned subsidiary with an investment of 10 million yuan in cash, aimed at achieving the company's global strategy objectives and development needs, optimizing structure, and controlling risks, for further investments in the semiconductors industry. This external investment to establish a wholly-owned subsidiary is to meet the company's future needs for further private equity investments in Suzhou Chipwise Semiconductor Technology Co., Ltd., and Chipwise New (Suzhou) Technology Co., Ltd. and its affiliates, continuing to expand the company's strategic layout in the fields of semiconductor materials, consumables, and equipment, and increase and enhance the company.
Dalian BIO-CHEM's (SHSE:603360) Earnings Growth Rate Lags the 53% CAGR Delivered to Shareholders
Dalian Bio-Chem (603360.SH): Has not yet invested in Xinhui Lianxin.
Grainhunter November 11th | Dalian Bio-Chem (603360.SH) announced that its wholly-owned subsidiary Xin'ao Hua has signed a letter of intent for equity investment with Xinhui Lianxin. The two parties have made tentative agreements on Xin'ao Hua's planned capital increase with Xinhui Lianxin, but the formal equity investment agreement has not been signed yet, and the company has not invested in Xinhui Lianxin. Currently, Xinhui Lianxin is not a subsidiary of the company's equity company. There is still some uncertainty regarding the transaction. If the transaction is completed, the company will not gain control of Xinhui Lianxin and will not include it in the company's consolidated financial statements. The impact on the company's operations and performance will depend on the final transaction proposal and.
Dalian BIO-CHEM (SHSE:603360) Seems To Use Debt Quite Sensibly
Dalian BIO-CHEM Company Limited's (SHSE:603360) Share Price Boosted 42% But Its Business Prospects Need A Lift Too
No Data
